Page 5 - 《中国药房》2022年6期

CHINA PHARMACY

Volume 33，Number 6，March 30，2022

Semimonthly
Table of Contents

Guideline for the evaluation of medicine list in Chinese medical institutions ………………………………………
……………………………………… CHEN Hui，SU Guangquan，LIU Xiao，TIAN Fangyuan，GUAN Yingyun，
CHEN Tingting，ZHAO Yingnan，LIU Linlin，BIAN Xiaolan，XU Ting，LI Xiaoyu，SHEN Aizong，LIU Lihong（641）
Investigation and suggestions on the smoothness of reporting channels for adverse drug reaction of pharmaceutical

manufacturers in China based on the public perspective ……………………………………………… LIN Xiao，
WU Hongyan，WANG Long，HUANG Yan，HAO Xingmin，LI Xingchen，YU Jiangxia，TIAN Liudan，RONG Yi（653）
Analysis on the linkage of 415 generic medicines passing consistency evaluation and essential medicine list，
medical insurance list and centralized procurement list from the perspective of medicine accessibility …………
…………………………………………………………………… ZHANG Huan，XU Nuo，XU Gan，LIU Liping（661）
Evaluation of the rationality and feasibility of the grouping method for centralized procurement of insulin drugs in
Wuhan based on the results of questionnaire survey among endocrinology physicians ……………… HU Huizi，
WEN Xiaotong，YANG Ying，MAO Lining，WANG Zhaolun，LUO Jia，ZHANG Weichun，MAO Zongfu，CUI Dan（666）
Establishment of fingerprint，analysis of chemical pattern recognition and multi-index content determination of
Cynanchum auriculatum ………… SUN Jia，GOU Jian，QIN Lan，LIU Ting，PAN Jie，WEI Yu，LIU Chunhua（673）
Simultaneous determination of 7 components in Dipsacus asper by HPLC …………………………………………
……………… YANG Changgui，GONG Anhui，ZHANG Chenggang，XIAO Chenghong，FAN Di，ZHOU Tao（680）

In vitro inhibitory effects of acteoside on 6 kinds of CYP enzymes in liver microsomes of rats ……………………
…………………………………………… WANG Zhi，ZHANG Haibo，JU Bowei，HU Junping，YANG Jianhua（685）
Spectrum-effect relationship of anti-gastric ulcer effect of Shaoyao gancao decoction ……………………………
………………………………… HE Li，FU Zhili，XIONG Yan，ZHAO Kun，YANG Tao，YANG Ling，LIU Wen（693）
Study on pharmacodynamics and pharmacokinetics of Qinglian ningxin capsule in ischemic arrhythmia model rats
……………………………………………… LI Yan，SUN Hongsheng，LI Yue，SHI Baoyan，ZHANG Xueshun（699）
Quality evaluation of Xin’an capsules by combination of fingerprint，multi-component quantitative analysis and
chemical pattern recognition analysis ………………………………………………………………………………
……………… LI Yanrong，DU Yilong，SHEN Ying，WU Zhe，WANG Dixin，ZHAO Shengnan，PAN Haifeng（706）
Optimization of the extraction technology of volatile components from Wuyao decoction …………………………
…………………… CHENG Yuan，SUN Wuqian，LIU Mingsong，DENG Yawei，DUAN Xuhong，LI Chunhua（713）
Study on the improvement of quality standard for Niushanggui capsules ……………………………………………
……………………………………… HUANG Ping，FENG Youlong，ZHOU Juanjuan，SHI Pei，SHI Qingshui（718）
Optimization of the simultaneous extraction technology of dietary fiber and flavonoids from the peel of Prunus
armeniaca ……………………………………………………………………………………………………………
………… HUANG Qionglian，ZHOU Minxian，LONG Jiangling，HUANG Yingying，YANG Ting，XIA Quan（724）
Comparison of volatile components and principal component analysis of Cuscuta chinensis and its processed pro-

ducts ………………………………………………………… LIU Tianqi，JIANG Hanmei，TIAN Yu，LIU Jinmin（729）
Clinical observation of Shenxiang suhe pill in the adjuvant treatment of triple vessel lesion of coronary artery ……
……………………………………………………………… LI Jing，SUN Hongchun，DOU Shumei，ZHANG Yu（735）
Data mining of adverse drug reaction signals for ado-trastuzumab emtansine and brentuximab vedotin based on
FAERS database ………………………………… WU Ziyang，HE Na，CHENG Yinchu，ZHAI Suodi，LIU Wei（740）